News

The market for artificial sweeteners has been projected to increase by almost 75% from 2025 through 2033, or from $3.11 ...
A panelist discusses how personalized ITP care requires open conversations about testing costs, insurance coverage, and ...
Panelists discuss how mirdametinib's oral administration offers convenience and improves compliance, especially in pediatric patients, and how its ability to stabilize progressive, symptomatic ...
Panelists discuss how chronic neuroinflammation involves distinct mechanisms from acute relapses—including microglial activation, mitochondrial dysfunction, and iron deposition—necessitating dual ...
Panelists discuss how effective provider-patient communication about weight requires opening conversations with empathy and collaboration, using phrases like "I'm concerned about your weight" and ...
Black men who were identified as sexual minorities were more receptive to long-acting injectable pre-exposure prophylaxis ...
The Braidwood decision maintains the status quo for many patients, keeping preventive services covered by Medicaid under the ...
Nipocalimab's FDA approval revolutionizes generalized myasthenia gravis treatment, offering rapid symptom relief and improved ...
Depemokimab significantly reduces asthma exacerbations, benefiting patients regardless of their baseline asthma control levels. A biologics license application for depemokimab is currently being ...
Panelists discuss how patient financial burden varies significantly by insurance type and often leads to treatment ...
Panelists discuss how healthcare resource utilization is primarily driven by hospitalizations, medication costs, and ...
Alexander I. Spira, MD, PhD, of The US Oncology Network, discusses findings from the COCOON trial that show prophylactic ...